Tokyo, Japan

Teiji Wada

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Pioneering Innovations by Inventor Teiji Wada in Therapeutic Agents

Introduction: Teiji Wada is a notable inventor based in Tokyo, Japan, who has made significant contributions to the field of pharmaceuticals and therapeutic innovations. With a total of three patents to his name, his recent work focuses on the development of novel therapeutic agents utilizing cyclic dinucleotide (CDN) derivatives.

Latest Patents: Teiji Wada's recent patents showcase his commitment to advancing medical treatments. One of his notable inventions involves cyclic dinucleotide derivative-based antibody-drug conjugates, which aim to develop novel CDN derivatives with STING agonist activity. This innovation targets the creation of therapeutic agents and methods that effectively deliver these CDN derivatives to specific cells and organs, addressing diseases linked to STING agonist activity. Additionally, Wada's work includes a pharmaceutical composition that combines an antibody-drug conjugate with an immune checkpoint inhibitor. This combination is designed to activate antitumor immunity, contributing to the treatment of various diseases.

Career Highlights: Teiji Wada is currently employed by Daiichi Sankyo Company, Limited, a leading enterprise known for its dedication to innovation in pharmaceutical development. His expertise and contributions have played a crucial role in enhancing the company’s portfolio of therapeutic solutions.

Collaborations: Throughout his career, Wada has worked closely with colleagues such as Tomomi Iwata and Chiaki Ishii. Their collaboration has been instrumental in advancing their research and contributing to the successful development of innovative therapeutic approaches.

Conclusion: Teiji Wada's innovative spirit and dedication to research are evident in his impactful patents and ongoing projects. His contributions to the field of therapeutic agents, particularly through the development of CDN derivatives, highlight the important intersection of science and innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…